{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:07Z","timestamp":1793059987443,"version":"4.5.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,27]]},"DOI":"10.1097\/tp.0b013e318245f14c","type":"journal-article","created":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T11:44:00Z","timestamp":1328096640000},"page":"617-623","source":"Crossref","is-referenced-by-count":194,"title":["Hepatitis E Virus and the Kidney in Solid-Organ Transplant Patients"],"prefix":"10.1097","volume":"93","author":[{"given":"Nassim","family":"Kamar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Weclawiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Guilbeau-Frugier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Legrand-Abravanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Cointault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ribes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Cardeau-Desangles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Guitard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Sallusto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Muscari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marie","family":"Peron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Alric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Izopet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Rostaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210129","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":". Hepatitis E virus and chronic hepatitis in organ-transplant recipients.","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"key":"R2-9-20210129","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/lt.21480","article-title":". Chronic hepatitis E virus infection in liver transplant recipients.","volume":"14","author":"Haagsma","year":"2008","journal-title":"Liver Transpl"},{"key":"R3-9-20210129","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJMc0903778","article-title":". Persistent carriage of hepatitis E virus in patients with HIV infection.","volume":"361","author":"Dalton","year":"2009","journal-title":"N Engl J Med"},{"key":"R4-9-20210129","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":". Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants.","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"key":"R5-9-20210129","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/0003-4819-150-6-200903170-00026","article-title":". Chronic hepatitis after hepatitis e virus infection in a patient with non-hodgkin lymphoma taking rituximab.","volume":"150","author":"Ollier","year":"2009","journal-title":"Ann Intern Med"},{"key":"R6-9-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcv.2010.02.016","article-title":". Severe thrombocytopenia associated with acute autochthonous hepatitis E.","volume":"48","author":"Fourquet","year":"2010","journal-title":"J Clin Virol"},{"key":"R7-9-20210129","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3201\/eid1702.100856","article-title":". Hepatitis E virus and neurologic disorders.","volume":"17","author":"Kamar","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R8-9-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/j.ajkd.2004.09.006","article-title":". Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient.","volume":"45","author":"Kamar","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R9-9-20210129","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/snep.2002.33677","article-title":"Hepatitis C virus infection and kidney transplantation.","volume":"22","author":"Morales","year":"2002","journal-title":"Semin Nephrol"},{"key":"R10-9-20210129","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/sj.ki.5000142","article-title":"Treatment of hepatitis C-virus-related glomerulonephritis.","volume":"69","author":"Kamar","year":"2006","journal-title":"Kidney Int"},{"key":"R11-9-20210129","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/00007890-199505270-00012","article-title":". Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.","volume":"59","author":"Rostaing","year":"1995","journal-title":"Transplantation"},{"key":"R12-9-20210129","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1097\/01.tp.0000183749.79424.b4","article-title":". Rituximab therapy for de novo mixed cryoglobulinemia in renal-transplant patients.","volume":"80","author":"Basse","year":"2005","journal-title":"Transplantation"},{"key":"R13-9-20210129","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1086\/650488","article-title":". Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation.","volume":"50","author":"Kamar","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R14-9-20210129","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/lt.22014","article-title":". Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b.","volume":"16","author":"Haagsma","year":"2010","journal-title":"Liver Transpl"},{"key":"R15-9-20210129","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1053\/j.gastro.2010.08.002","article-title":". Ribavirin therapy inhibits viral replication in patients with chronic hepatitis E virus infection.","volume":"139","author":"Kamar","year":"2010","journal-title":"Gastroenterology"},{"key":"R16-9-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-153-2-201007200-00257","article-title":". Brief communication: Case reports of ribavirin treatment for chronic hepatitis E.","volume":"153","author":"Mallet","year":"2010","journal-title":"Ann Intern Med"},{"key":"R17-9-20210129","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/ndt\/gfq718","article-title":". Kidney histology and function in liver transplant patients.","volume":"26","author":"Kamar","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R18-9-20210129","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/TP.0b013e3181c4096c","article-title":". Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation.","volume":"89","author":"Kamar","year":"2010","journal-title":"Transplantation"},{"key":"R19-9-20210129","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jmv.20206","article-title":". Hepatitis E in the south west of France in individuals who have never visited an endemic area.","volume":"74","author":"Mansuy","year":"2004","journal-title":"J Med Virol"},{"key":"R20-9-20210129","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3201\/eid1501.080296","article-title":". Hepatitis E virus genotype 3 diversity, France.","volume":"15","author":"Legrand-Abravanel","year":"2009","journal-title":"Emerg Infect Dis"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e318245f14c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T17:10:24Z","timestamp":1742404224000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201203270-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,27]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318245f14c","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3,27]]}}}